Back Bay Life Science Advisors is a U.S.-based firm specializing in integrated strategy consulting and investment banking for the life sciences sector. The firm provides guidance to biotech, pharmaceutical, and medical technology companies and their investors on issues such as development, commercialization, growth, and market share maintenance. Their approach focuses on delivering clear and unbiased advice for critical value-driving decisions.
In 2023, Back Bay formed a strategic partnership with DNB Bank to enhance their service offerings. This collaboration aims to provide healthcare companies with comprehensive strategic guidance, M&A and partnering support, and execution capabilities in global capital markets and both investment and commercial banking. Together, they offer specialized support across the full continuum of life science and healthcare development.